23andMe
me anti antibody for hard to treat solid tumors phase a me | 23andMe
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
22 of 39
Related slides by other companies
Nuvalent
Investor Presentation
October 2023
for positive advanced and other solid tumors resistance mutations | Nuvalent
Recursion Pharmaceuticals
Investor Day
January 2023
for the treatment of solid tumors with mutant cancers | Recursion Pharmaceuticals
Nuvalent
Investor Presentation
November 2023
for positive advanced and other solid tumors | Nuvalent
Aeglea BioTherapeutics
Investor Presentation
October 2023
spy summary i | Aeglea BioTherapeutics
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Presentation
February 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io